FIELD: biotechnology.
SUBSTANCE: proposed is a binding molecule containing a first, a second, a third, and a fourth polypeptides. The first polypeptide and the second polypeptide comprise a light antibody chain. The third polypeptide comprises a first variable heavy chain region (VH), a first constant heavy chain region (CH1), and a second VH region. The fourth polypeptide comprises a third VH region, a second CH1 region, and a variable light chain region (VL). The first polypeptide together with the first VH region and the first CH1 region of the third polypeptide form a first antigen-binding region Fab. The second polypeptide together with the third VH region and the second CH1 region of the fourth polypeptide form a second antigen-binding Fab region. The second VH region of the third polypeptide and the VL region of the fourth polypeptide form a Fv region binding to CD3. The first and second Fab regions are connected with the Fv by a flexible peptide region containing a hinge antibody site. The first and second Fab regions bind to the same antigen. The invention also relates to a method for producing said molecule and to a pharmaceutical composition containing said molecule.
EFFECT: invention can be used in immunotherapy of cancer.
18 cl, 73 dwg, 14 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
SPECIFIC TO MUCIN-1 POLYPEPTIDE AND ITS USE | 2021 |
|
RU2805840C1 |
ANTIBODIES CONTAINING POLYPEPTIDE INTEGRATED INTO FRAME REGION 3 | 2019 |
|
RU2796254C2 |
LY6G6D ANTIBODIES AND METHODS OF USE | 2020 |
|
RU2818569C1 |
ANTIBODIES AGAINST CD40 AND THEIR USE | 2018 |
|
RU2796413C2 |
BISPECIFIC ANTIGEN-BINDING MOLECULES CONTAINING ANTI-FAP CLONE 212 | 2019 |
|
RU2799429C2 |
METHODS FOR DETECTING FOLATE RECEPTOR 1 IN PATIENT SAMPLE | 2018 |
|
RU2759410C2 |
ANTIBODIES AGAINST CTLA4 AND THEIR USE | 2017 |
|
RU2779312C2 |
ANTIBODIES BINDING TO GPRC5D | 2019 |
|
RU2797268C2 |
ANTIBODIES TO CHIMERIC ANTIGEN RECEPTORS DERIVED FROM 4G7 | 2020 |
|
RU2826051C2 |
ANTI-IL-22R-ANTIBODIES | 2017 |
|
RU2758721C2 |
Authors
Dates
2022-04-19—Published
2019-04-09—Filed